The global anti-obesity drugs market size is set to grow significantly owing to the ever-increasing prevalence of obesity among the global population, observes Fortune Business Insights™ in its report, titled, “Anti-obesity Drugs Market Size, Share & COVID-19 Impact Analysis, By Type (Prescription Drugs and OTC Drugs), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The market size was USD 1,520.2 million in 2019 and is anticipated to reach USD 3,421.0 million by 2027, exhibiting a CAGR of 10.1% during the forecast period.
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/anti-obesity-drugs-market-104783
| North America | United States, Canada and Mexico |
| Europe | Germany, UK, France, Italy, Russia and Turkey etc. |
| Asia-Pacific | China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc. |
| South America | Brazil, Argentina, Columbia etc. |
| Middle East & Africa | Saudi Arabia, UAE, Egypt, Nigeria and South Africa |
Rising Prevalence of Obesity Worldwide to Drive Growth
Owing to poor lifestyle choices and unhealthy eating habits, the world is on the verge of an obesity pandemic. The increasing cases of obesity worldwide are driving the anti-obesity drugs market growth. For instance, according to the World Obesity Federation, there are 650 million adults along with 120 million children currently suffering from obesity. In addition, increasing research and development activities by key players to introduce effective anti-obesity drugs are estimated to further enhance growth. However, the lack of knowledge regarding the efficacy of such anti-obesity drugs may hinder growth in the future.
Healthcare Sector to Stumble amid COVID-19 Pandemic
The healthcare sector has been the most active ever since the COVID-19 outbreak. While the pandemic has fast-tracked the development of the industry on a global scale, it has also brought numerous adversities upon the sector. These adversities include limited infrastructure in developing countries and the lack of preparedness in case of health emergencies. Key players are focusing on eliminating such challenges. At Fortune Business Insights, we are constantly analyzing the market conditions to offer the most effective solutions at your service.
Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anti-obesity-drugs-market-104783
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245Email:sales@fortunebusinessinsights.com